54636-77-0

Basic information

• Product Name: 2,3-Dimethoxybenzylbromide
• Synonyms: 2,3-Dimethoxybenzylbromide
• CAS NO: 54636-77-0
• Molecular Formula: C₉H₁₁BrO₂
• Molecular Weight: 231.09
• Mol File: 54636-77-0.mol
• Article Data: 18

Chemical Properties

• Melting Point: 27-29 °C
• Boiling Point: 140-142 °C(Press: 11.0 Torr)
• Appearance: /
• Density: 1.384±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2,3-Dimethoxybenzylbromide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Dimethoxybenzylbromide(54636-77-0)
• EPA Substance Registry System: 2,3-Dimethoxybenzylbromide(54636-77-0)

Safety Data

• Hazardous Substances Data: 54636-77-0(Hazardous Substances Data)

Usage

General Description

2,3-Dimethoxybenzylbromide is a chemical compound with a molecular formula C9H11BrO2. It is a colorless to pale yellow liquid with a molecular weight of 221.085 g/mol. The compound is primarily used as an intermediate in the synthesis of organic compounds and pharmaceuticals. It is commonly utilized in the preparation of various benzyl derivatives and is also employed in organic synthesis as a reagent. 2,3-Dimethoxybenzylbromide is known to have potential health hazards and must be handled with care in a well-ventilated area with appropriate protective equipment.

Upstream product

• 86-51-1 2,3-dimethyoxybenzaldehyde 
• 5653-67-8 2,3-dimethoxybenzyl alcohol 

Downstream Products

• 4468-57-9 2-(2,3-dimethoxyphenyl)acetonitrile 
• 1012321-37-7 C₂₄H₂₆O₄ 
• 1272974-73-8 3,5-dimethoxy-4-(2',3'-dimethoxybenzyloxy)benzaldehyde 
• 1356199-39-7 7-[3-(benzylideneamino)methyl-4-(2',3'-dimethxoybenzyloxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid 
• 1356199-06-8 C₂₄H₃₇N₃O₇ 
• 73645-03-1 1,2,4,5-tetrahydro-1-(2,3-dimethoxybenzyl)-3-methyl-3H-3-benzazepin-2-one 
• 75428-25-0 1-(2,3-dimethoxybenzyl)-7,8-dimethoxy-3-methyl-1,2,4,5-tetrahydro-3H-3-benzazepin-2-one 
• 75428-27-2 1-(2,3-dimethoxybenzyl)-7,8-methylenedioxy-3-methyl-1,2,4,5-tetrahydro-3H-3-benzazepin-2-one 
• 39964-91-5 N-(2,3-Dimethoxy-benzyl)-N-(2,2-dimethoxy-ethyl)-4-methyl-benzenesulfonamide 
• 100059-50-5 (2,3-dimethoxy-benzylsulfanyl)-acetic acid 

Relevant articles and documents

3, 5-disubstituted hydantoin compound as well as preparation method and application thereof

The invention provides a 3, 5-disubstituted hydantoin compound as well as a preparation method and an application thereof. The structure of the compound is shown in formula I in the description. The application of the 3, 5-disubstituted hydantoin compound shown in the formula I or solvates, hydrates or salts of the compound in preparation of medicines for treating Alzheimer's disease, vascular dementia and other dementia diseases with memory impairment also belongs to the protection scope. Animal experiments prove that the compound has the effect of saving memory of animal models, has high safety, does not have mutagenicity, can stay in blood for several hours after oral administration and intravenous injection, and can enter the brain.

MLKL INHIBITORS

Purine derivatives that inhibit cellular necroptosis and/or human MLKL, pharmaceutical compositions thereof, and methods of treating an MLKL-mediated disorder with an effective amount of the compound or composition. Said MLKL-mediated disorder is pathology associated necroptosis, including ischemia-reperfusion damage, neurodegeneration, and inflammatory diseases such as acute pancreatitis, multiple sclerosis, inflammatory bowel disease, and allergic colitis.

4-oxo-alkylated tetramic acid compound as well as preparation method and application thereof

The invention relates to a novel compound as well as preparation method and application thereof. The structural formula of the novel compound is as shown in a formula I. Animal tests show that the compound provided by the invention has a memory effect of rescuing animal models, is high in security and free of mutagenicity induction, can be retained for hours in blood after oral taking and intravenous injection, can be fed into brains and can be used for preparing medicines for treating senile dementia, Parkinsonism, Huntington diseases, vascular dementia, schizophrenia, autism and the like.